Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 |
| Gross Profit | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 |
| Operating Expenses | 26,445 | 28,920 | 29,822 | 27,954 | 27,705 |
| Operating Income | -6,455 | -2,725 | -14,434 | -9,200 | -10,837 |
| Interest Expense | 573 | 663 | 643 | 643 | 630 |
| Other Income | 4,139 | 76,594 | 939 | 904 | 1,415 |
| Pre-tax Income | -2,889 | 73,206 | -14,138 | -8,939 | -10,052 |
| Income Tax | -6,504 | 18,371 | -559 | 6,588 | 2,646 |
| Net Income Continuous | 3,615 | 54,835 | -13,579 | -15,527 | -12,698 |
| Net Income | $3,615 | $54,835 | $-13,579 | $-15,527 | $-12,698 |
| EPS Basic Total Ops | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 |
| EPS Basic Continuous Ops | 0.07 | 1.09 | -0.27 | -0.32 | -0.26 |
| EPS Diluted Total Ops | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 |
| EPS Diluted Continuous Ops | 0.07 | 1.08 | -0.27 | -0.32 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.03 | 1.08 | -0.27 | -0.31 | -0.26 |
| EBITDA(a) | $-6,821 | $-2,738 | $-14,348 | $-9,558 | $-11,204 |